Posts by tag
trials
Geriatric oncology: how physicians in Latin America are personalising treatments and changing attitudes
When Gerardo Silveyra, a retired chemist from Toluca, Mexico, thinks about his recently deceased mother, Guadalupe Contreras, he regrets not having taken her to see a geriatrician sooner. Contreras, who died aged 93, had been “a very active woman,” and…
CAR T cells v chemo for childhood leukaemia: are we ready for the next step?
Chimeric antigen receptor (CAR) T cells, genetically engineered immune cells targeted to attack cancers, are one of the most exciting breakthrough cancer treatments in oncology today. After decades of incremental development, its clinical efficacy was shown in 2010, with the…
North and South ‒ learning faster means learning together
When you look at the vast waiting area in Mumbai’s world leading Tata Memorial Cancer Hospital, pictured above, what do you see? A crowded chaotic scene where sick patients and their relatives sit around for hours, waiting, hoping for someone…
Cancer trials interruption in Latin America halts treatment for many
The interruption of cancer clinical trials across Latin America due to the COVID-19 pandemic is threatening the treatment of thousands of patients in the public health system. A JCO Global Oncology study, conducted by the Latin American Cooperative Oncology Group…
Older, frail patients are still being let down by the regulators
Hans Wildiers is frustrated. “This drug is well-tolerated in older persons – this is a very frequent conclusion in publications. And it is often not a correct conclusion,” says the immediate past president of SIOG, the International Society of Geriatric…